These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29916740)

  • 1. Preserving Skin Integrity with Chronic Device Use in Diabetes.
    Messer LH; Berget C; Beatson C; Polsky S; Forlenza GP
    Diabetes Technol Ther; 2018 Jun; 20(S2):S254-S264. PubMed ID: 29916740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
    Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
    Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequencies of dermatological complications in children using insulin pumps or sensors.
    Berg AK; Olsen BS; Thyssen JP; Zachariae C; Simonsen AB; Pilgaard K; Svensson J
    Pediatr Diabetes; 2018 Jun; 19(4):733-740. PubMed ID: 29484783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Sticking Point: How to tackle irritation from infusion set and CGM sensor adhesives.
    Tsai A
    Diabetes Forecast; 2017 Mar; 70(2):28-31. PubMed ID: 29897681
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study.
    Diedisheim M; Pecquet C; Julla JB; Carlier A; Potier L; Hartemann A; Jacqueminet S; Vidal-Trecan T; Gautier JF; Dubois Laforgue D; Fagherazzi G; Roussel R; Larger E; Sola-Gazagnes A; Riveline JP
    Diabetes Technol Ther; 2023 Apr; 25(4):279-286. PubMed ID: 36763338
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
    Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
    J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric diabetes and skin disease (PeDiSkin): A cross-sectional study in 369 children, adolescents and young adults with type 1 diabetes.
    Burgmann J; Biester T; Grothaus J; Kordonouri O; Ott H
    Pediatr Diabetes; 2020 Dec; 21(8):1556-1565. PubMed ID: 32985057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
    ; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
    Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.
    Christensen MO; Berg AK; Rytter K; Hommel E; Thyssen JP; Svensson J; Nørgaard K
    Diabetes Technol Ther; 2019 Apr; 21(4):215-221. PubMed ID: 30943072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contact allergy due to insulin pumps and glucose sensor systems].
    Wagner N; Kamann S; Oppel E
    Hautarzt; 2020 Mar; 71(3):205-210. PubMed ID: 31965206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue.
    Lombardo F; Salzano G; Crisafulli G; Panasiti I; Alibrandi A; Messina MF; Pajno GB; Caminiti L; Passanisi S
    Diabetes Res Clin Pract; 2020 Apr; 162():108089. PubMed ID: 32087268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Response to Subcutaneous Infusion Catheter.
    Zhang E; Cao Z
    J Diabetes Sci Technol; 2020 Mar; 14(2):226-232. PubMed ID: 30931603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of Safety Issues on Use of Insulin Pumps and Continuous Glucose Monitoring Systems in the Hospital.
    Thompson B; Leighton M; Korytkowski M; Cook CB
    Curr Diab Rep; 2018 Aug; 18(10):81. PubMed ID: 30120619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.
    Galderisi A; Sherr JL
    Pediatr Ann; 2019 Aug; 48(8):e311-e318. PubMed ID: 31426099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes.
    Genève P; Adam T; Delawoevre A; Jellimann S; Legagneur C; DiPatrizio M; Renard E
    Diabetes Res Clin Pract; 2023 Oct; 204():110922. PubMed ID: 37769906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey.
    Lombardo F; Passanisi S; Tinti D; Messina MF; Salzano G; Rabbone I
    J Diabetes Sci Technol; 2021 Nov; 15(6):1377-1381. PubMed ID: 32757778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.